Literature DB >> 28660566

Screening of BMPR1a for pathogenic mutations in familial colorectal cancer type X families from Newfoundland.

Daniel R Evans1, Jane S Green1, Michael O Woods2.   

Abstract

The Canadian province of Newfoundland and Labrador (NL) reports one of the highest incidence rates of familial colorectal cancer (CRC) worldwide. The NL population is an invaluable resource for studying genetic disorders because of a unique ancestry, and a willingness to participate in research studies. Familial colorectal cancer type X (FCCTX) describes a cluster of families with strong predisposition for CRC, of unknown etiology. A putative link between FCCTX and BMPR1a mutations has been identified in the Finnish population; however these findings have not been independently replicated. To investigate a potential connection between BMPR1a and FCCTX, we screened a cohort of 22 probands from unrelated NL FCCTX families using Sanger sequencing. This analysis did not independently replicate findings seen in Finland; as no candidate pathogenic BMPR1a mutations were uncovered. Our findings highlight that BMPR1a mutations are not a major contributor of FCCTX incidence in NL. Further investigation of additional FCCTX populations may assist in delineating a role for BMPR1a, if any, in FCCTX globally.

Entities:  

Keywords:  BMPR1a; Candidate gene; Familial colorectal cancer type X; Newfoundland and Labrador

Mesh:

Substances:

Year:  2018        PMID: 28660566     DOI: 10.1007/s10689-017-0016-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  8 in total

1.  BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency.

Authors:  Taina T Nieminen; Wael M Abdel-Rahman; Ari Ristimäki; Maarit Lappalainen; Päivi Lahermo; Jukka-Pekka Mecklin; Heikki J Järvinen; Päivi Peltomäki
Journal:  Gastroenterology       Date:  2011-06-01       Impact factor: 22.682

2.  BMPR1A mutations in early-onset colorectal cancer with mismatch repair proficiency.

Authors:  C Fernandez-Rozadilla; A Brea-Fernández; X Bessa; C Alvarez-Urturi; A Abulí; J Clofent; A Payá; R Jover; R Xicola; X Llor; M Andreu; A Castells; A Carracedo; S Castellví-Bel; C Ruiz-Ponte
Journal:  Clin Genet       Date:  2012-10-12       Impact factor: 4.438

3.  The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease.

Authors:  M O Woods; H B Younghusband; P S Parfrey; S Gallinger; J McLaughlin; E Dicks; S Stuckless; A Pollett; B Bapat; M Mrkonjic; A de la Chapelle; M Clendenning; S N Thibodeau; M Simms; A Dohey; P Williams; D Robb; C Searle; J S Green; R C Green
Journal:  Gut       Date:  2010-08-03       Impact factor: 23.059

4.  A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.

Authors:  G Warden; D Harnett; J Green; T Wish; M O Woods; R Green; E Dicks; P Rahman; G Zhai; P Parfrey
Journal:  Clin Genet       Date:  2013-02-07       Impact factor: 4.438

5.  Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies.

Authors:  R C Green; J S Green; S K Buehler; J D Robb; D Daftary; S Gallinger; J R McLaughlin; P S Parfrey; H B Younghusband
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

6.  Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.

Authors:  Noralane M Lindor; Kari Rabe; Gloria M Petersen; Robert Haile; Graham Casey; John Baron; Steve Gallinger; Bharati Bapat; Melyssa Aronson; John Hopper; Jeremy Jass; Loic LeMarchand; John Grove; John Potter; Polly Newcomb; Jonathan P Terdiman; Peggy Conrad; Gabriella Moslein; Richard Goldberg; Argyrios Ziogas; Hoda Anton-Culver; Mariza de Andrade; Kim Siegmund; Stephen N Thibodeau; Lisa A Boardman; Daniela Seminara
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

7.  Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.

Authors:  Daniel Chubb; Peter Broderick; Sara E Dobbins; Matthew Frampton; Ben Kinnersley; Steven Penegar; Amy Price; Yussanne P Ma; Amy L Sherborne; Claire Palles; Maria N Timofeeva; D Timothy Bishop; Malcolm G Dunlop; Ian Tomlinson; Richard S Houlston
Journal:  Nat Commun       Date:  2016-06-22       Impact factor: 14.919

8.  Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.

Authors:  Clara Esteban-Jurado; Maria Vila-Casadesús; Pilar Garre; Juan José Lozano; Anna Pristoupilova; Sergi Beltran; Jenifer Muñoz; Teresa Ocaña; Francesc Balaguer; Maria López-Cerón; Miriam Cuatrecasas; Sebastià Franch-Expósito; Josep M Piqué; Antoni Castells; Angel Carracedo; Clara Ruiz-Ponte; Anna Abulí; Xavier Bessa; Montserrat Andreu; Luis Bujanda; Trinidad Caldés; Sergi Castellví-Bel
Journal:  Genet Med       Date:  2014-07-24       Impact factor: 8.822

  8 in total
  1 in total

Review 1.  Hereditary Nonpolyposis Colorectal Cancer and Cancer Syndromes: Recent Basic and Clinical Discoveries.

Authors:  Erbao Chen; Xiaojing Xu; Tianshu Liu
Journal:  J Oncol       Date:  2018-04-23       Impact factor: 4.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.